Trials / Completed
CompletedNCT00989313
A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
A 12 Month, Long-term Follow-up Study of Patients With Actinic Keratosis on Non-head Locations (Trunk and Extremities) Who Have Completed Day 57 in Study PEP005-028 (REGION Ib)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Peplin · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to follow up patients, who have participated in the PEP005-028 study and observed complete clearance of their Actinic Keratosis (AK) lesions, over a 12 month period to assess both recurrence of AK lesions and long term safety in the selected treatment area.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lesion count | Lesion count in area treated by study drug in a prior study. No drug will be applied during this long-term follow up study. Drug was applied during the primary study. |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2009-10-05
- Last updated
- 2015-03-26
Locations
17 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00989313. Inclusion in this directory is not an endorsement.